| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |